home / stock / pulm / pulm short
Short Information | Pulmatrix Inc. (NASDAQ:PULM)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 38,993 |
Total Actual Volume | 220,586 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 1 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 1,950 |
Average Short Percentage | 14.76% |
Is there a PULM Short Squeeze or Breakout about to happen?
See the PULM Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-05-2024 | $2.16 | $2.1101 | $2.16 | $2.01 | 23,035 | 3,213 | 13.95% |
07-03-2024 | $1.99 | $2.19 | $2.19 | $1.99 | 20,418 | 2,668 | 13.07% |
07-02-2024 | $1.9799 | $2 | $2.1 | $1.97 | 71,267 | 19,664 | 27.59% |
07-01-2024 | $1.98 | $1.96 | $1.98 | $1.9401 | 3,844 | 455 | 11.84% |
06-28-2024 | $1.93 | $1.93 | $1.97 | $1.92 | 12,519 | 616 | 4.92% |
06-27-2024 | $1.91 | $1.95 | $1.9667 | $1.91 | 3,214 | 153 | 4.76% |
06-26-2024 | $1.95 | $1.95 | $1.97 | $1.88 | 6,587 | 516 | 7.83% |
06-25-2024 | $1.9 | $1.95 | $1.98 | $1.9 | 3,928 | 315 | 8.02% |
06-24-2024 | $1.92 | $1.93 | $1.97 | $1.9 | 7,714 | 116 | 1.5% |
06-21-2024 | $1.87 | $1.98 | $1.98 | $1.87 | 7,775 | 211 | 2.71% |
06-20-2024 | $1.9325 | $1.9299 | $1.96 | $1.88 | 5,137 | 738 | 14.37% |
06-18-2024 | $1.8702 | $1.92 | $1.9826 | $1.8702 | 4,987 | 414 | 8.3% |
06-17-2024 | $1.91 | $1.95 | $1.96 | $1.9001 | 3,526 | 152 | 4.31% |
06-14-2024 | $1.9 | $1.9177 | $1.96 | $1.85 | 7,754 | 2,498 | 32.22% |
06-13-2024 | $1.92 | $1.8899 | $1.92 | $1.8846 | 3,366 | 1,270 | 37.73% |
06-12-2024 | $1.83 | $1.8901 | $1.891 | $1.83 | 3,805 | 315 | 8.28% |
06-11-2024 | $1.91 | $1.916 | $1.94 | $1.851 | 13,820 | 2,540 | 18.38% |
06-10-2024 | $1.9 | $1.9651 | $1.97 | $1.9 | 5,783 | 114 | 1.97% |
06-07-2024 | $1.9 | $1.97 | $1.98 | $1.9 | 3,058 | 1,845 | 60.33% |
06-06-2024 | $1.93 | $1.9 | $1.97 | $1.83 | 9,049 | 1,180 | 13.04% |
News, Short Squeeze, Breakout and More Instantly...
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation PR Newswire Cross license involves Pulmatrix iSPERSE™ technology and MannKind's Cricket ® inhalation device. Pulmatrix transferring leased building,...
Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100) PR Newswire Orally Inhaled PUR3100 is associated with rapid systemic PK within the therapeutic window and a mean time to Cmax matching intravenously (IV) a...